Expired activity
Please go to the PowerPak homepage and select a course.

Alzheimer's Disease: Addressing the Underlying Mechanisms of Preclinical Disease and Mild Cognitive Impairment (Recorded Podcast)

» References (PDF)

FACULTY

Jessica Inez Mazur Pyhtila, PharmD, BCGP, BCPS
Clinical Pharmacy Specialist, Home Based Primary Care
Veterans Affairs Maryland Health Care System
Baltimore, Maryland

LEARNING OBJECTIVES

Upon completion of this program, participants should be better able to:

  • Discuss the underlying pathologic mechanisms of preclinical AD and mild cognitive impairment, biomarkers of early brain changes and advances in research in therapeutic strategies to improve outcomes
  • Explain safety and efficacy data and ongoing investigations into disease modifying therapies for AD, including anti-amyloid agents

Back to Top